Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$101.01
+0.0%
$99.72
$92.44
$101.02
$3.32B0.89509,062 shs1.06 million shs
Chemed Corporation stock logo
CHE
Chemed
$419.07
-0.1%
$415.27
$365.20
$562.77
$5.57B0.54190,637 shs154,842 shs
CorVel Corp. stock logo
CRVL
CorVel
$60.34
$57.99
$44.83
$106.16
$3.06B0.99222,599 shs163,254 shs
DaVita Inc. stock logo
DVA
DaVita
$208.31
-0.2%
$176.13
$101.00
$211.80
$13.37B0.91771,908 shs936,580 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
0.00%0.00%0.00%0.00%+3.96%
Chemed Corporation stock logo
CHE
Chemed
0.00%-4.90%-3.54%+5.06%-23.85%
CorVel Corp. stock logo
CRVL
CorVel
0.00%+0.79%+5.66%+12.30%-42.57%
DaVita Inc. stock logo
DVA
DaVita
0.00%+8.33%+4.45%+40.67%+53.25%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amedisys, Inc. stock logo
AMED
Amedisys
$101.01
+0.0%
$99.72
$92.44
$101.02
$3.32B0.89509,062 shs1.06 million shs
Chemed Corporation stock logo
CHE
Chemed
$419.07
-0.1%
$415.27
$365.20
$562.77
$5.57B0.54190,637 shs154,842 shs
CorVel Corp. stock logo
CRVL
CorVel
$60.34
$57.99
$44.83
$106.16
$3.06B0.99222,599 shs163,254 shs
DaVita Inc. stock logo
DVA
DaVita
$208.31
-0.2%
$176.13
$101.00
$211.80
$13.37B0.91771,908 shs936,580 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amedisys, Inc. stock logo
AMED
Amedisys
0.00%0.00%0.00%0.00%+3.96%
Chemed Corporation stock logo
CHE
Chemed
0.00%-4.90%-3.54%+5.06%-23.85%
CorVel Corp. stock logo
CRVL
CorVel
0.00%+0.79%+5.66%+12.30%-42.57%
DaVita Inc. stock logo
DVA
DaVita
0.00%+8.33%+4.45%+40.67%+53.25%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amedisys, Inc. stock logo
AMED
Amedisys
0.00
N/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
2.33
Hold$501.5019.67% Upside
CorVel Corp. stock logo
CRVL
CorVel
1.00
SellN/AN/A
DaVita Inc. stock logo
DVA
DaVita
2.38
Hold$199.17-4.39% Downside

Current Analyst Ratings Breakdown

Latest AMED, DVA, CHE, and CRVL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/8/2026
DaVita Inc. stock logo
DVA
DaVita
Reiterated RatingHold (C+)
5/11/2026
DaVita Inc. stock logo
DVA
DaVita
Boost Price TargetHold$144.00 ➝ $201.00
5/11/2026
DaVita Inc. stock logo
DVA
DaVita
Boost Price TargetHold$144.00 ➝ $201.00
5/8/2026
DaVita Inc. stock logo
DVA
DaVita
Boost Price TargetHold$158.00 ➝ $205.00
5/7/2026
DaVita Inc. stock logo
DVA
DaVita
Boost Price TargetEqual Weight$158.00 ➝ $194.00
5/7/2026
DaVita Inc. stock logo
DVA
DaVita
UpgradeHoldStrong-Buy
5/7/2026
DaVita Inc. stock logo
DVA
DaVita
Boost Price TargetBuy$190.00 ➝ $235.00
5/6/2026
DaVita Inc. stock logo
DVA
DaVita
UpgradeHoldBuy$126.00 ➝ $220.00
4/29/2026
Chemed Corporation stock logo
CHE
Chemed
UpgradeSell (D+)Hold (C-)
4/27/2026
Chemed Corporation stock logo
CHE
Chemed
Boost Price TargetSector Perform$422.00 ➝ $436.00
4/27/2026
Chemed Corporation stock logo
CHE
Chemed
UpgradeStrong SellHold
(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amedisys, Inc. stock logo
AMED
Amedisys
$2.40B1.38$6.24 per share16.20$38.77 per share2.61
Chemed Corporation stock logo
CHE
Chemed
$2.54B2.19$24.65 per share17.00$69.15 per share6.06
CorVel Corp. stock logo
CRVL
CorVel
$958.53M3.19$2.78 per share21.72$7.71 per share7.83
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.98$21.68 per share9.61($5.29) per share-39.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amedisys, Inc. stock logo
AMED
Amedisys
$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/A
Chemed Corporation stock logo
CHE
Chemed
$265.24M$18.3522.8416.451.5710.23%27.18%17.38%8/4/2026 (Estimated)
CorVel Corp. stock logo
CRVL
CorVel
$110.34M$2.1428.20N/AN/A11.51%29.92%17.68%8/4/2026 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$746.80M$10.7819.3211.340.685.65%-270.37%4.87%8/5/2026 (Estimated)

Latest AMED, DVA, CHE, and CRVL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2026Q4 2026
CorVel Corp. stock logo
CRVL
CorVel
N/A$0.61N/A$0.61N/A$248.55 million
5/5/2026Q1 2026
DaVita Inc. stock logo
DVA
DaVita
$2.33$2.87+$0.54$2.87$3.36 billion$3.42 billion
4/23/2026Q1 2026
Chemed Corporation stock logo
CHE
Chemed
$5.30$5.65+$0.35$4.84$659.22 million$657.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amedisys, Inc. stock logo
AMED
Amedisys
N/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$2.400.57%+10.76%13.08%16 Years
CorVel Corp. stock logo
CRVL
CorVel
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A

Latest AMED, DVA, CHE, and CRVL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/18/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.600.55%5/28/20265/28/20266/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amedisys, Inc. stock logo
AMED
Amedisys
0.26
1.36
1.36
Chemed Corporation stock logo
CHE
Chemed
0.11
0.85
0.83
CorVel Corp. stock logo
CRVL
CorVel
N/A
2.03
2.03
DaVita Inc. stock logo
DVA
DaVita
N/A
1.42
1.37

Institutional Ownership

CompanyInstitutional Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
94.36%
Chemed Corporation stock logo
CHE
Chemed
95.85%
CorVel Corp. stock logo
CRVL
CorVel
51.36%
DaVita Inc. stock logo
DVA
DaVita
90.12%

Insider Ownership

CompanyInsider Ownership
Amedisys, Inc. stock logo
AMED
Amedisys
2.10%
Chemed Corporation stock logo
CHE
Chemed
3.33%
CorVel Corp. stock logo
CRVL
CorVel
44.56%
DaVita Inc. stock logo
DVA
DaVita
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amedisys, Inc. stock logo
AMED
Amedisys
20,00032.89 million32.20 millionOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.27 million12.83 millionOptionable
CorVel Corp. stock logo
CRVL
CorVel
5,23950.69 million28.10 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00064.20 million63.24 millionOptionable

Recent News About These Companies

Best Growth Stocks to Buy for June 15th
Best Value Stocks to Buy for June 11th
Best Growth Stocks to Buy for June 11th
Best Growth Stocks to Buy for June 9th
Best Value Stocks to Buy for June 9th
Norges Bank Takes Position in DaVita Inc. $DVA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amedisys stock logo

Amedisys NASDAQ:AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Chemed stock logo

Chemed NYSE:CHE

$419.07 -0.24 (-0.06%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$419.37 +0.30 (+0.07%)
As of 06/12/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CorVel stock logo

CorVel NASDAQ:CRVL

$60.34 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$60.33 -0.01 (-0.02%)
As of 06/12/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

DaVita stock logo

DaVita NYSE:DVA

$208.31 -0.35 (-0.17%)
Closing price 06/12/2026 03:59 PM Eastern
Extended Trading
$208.82 +0.52 (+0.25%)
As of 06/12/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.